Pipeline · Cardiometabolic

Type 2 Diabetes.Pre-Clinical / Designed

Insulin-sensitisation and β-cell preservation focus. Continuous glucose monitoring as primary endpoint, HbA1c as secondary, fasting C-peptide as molecular biomarker.

Status: Pre-Clinical / Designed
Therapeutic area: Cardiometabolic
Key: CGM primary · β-cell axis
The premise

The mechanism we're betting on.

Insulin-sensitisation and β-cell preservation focus. Continuous glucose monitoring as primary endpoint, HbA1c as secondary, fasting C-peptide as molecular biomarker. The full mechanism map — including compound list, dose escalation, pre-specified biomarker thresholds, and the cross-walk modifiers used when re-fitting blends from related indications — is part of the gated methodology pack.Gated

RWE — real-world public landscape

What the rest of the world is doing.

Numbers below are surfaced by Atlas Bio's ClinicalTrials.gov and PubMed RWE pipelines, run against the Type 2 Diabetes indication. Counts are industry-wide trials registered on ClinicalTrials.gov, not Atlas Bio studies. Methodology →

RWE refreshed 2026-05-12
Phase I (B1/B2)
200
trials
Phase II (B3)
200
trials
Phase III (B4)
200
trials
Phase IV (B5)
200
trials
Top public trials by enrollment
NCT01633177 · Study of Vitamin D and Omega-3 Supplementation for Preventing Diabetes · Brigham and Women's Hospital · n=22,220 · PHASE3 · COMPLETED
NCT00741585 · Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment · University of Vigo · n=21,983 · PHASE4 · COMPLETED
NCT00000620 · Action to Control Cardiovascular Risk in Diabetes (ACCORD) · National Heart, Lung, and Blood Institute · n=10,251 · PHASE3 · COMPLETED
Recent published clinical evidence
Pre-registered predictions

Locked before readout.

Predictions for this study are SHA-256 locked before any readout. Pre-registration covers target engagement, primary endpoint, secondary endpoints, and the falsification criterion. The hash, prediction wording, and timestamp are available to verified clinicians and indication researchers on request.Gated

Methodology pillars used

Same stack, every indication.

Want the full Type 2 Diabetes protocol?

The abstract above is open. Compound lists, dose escalations, SHA-256-locked prediction documents, agent-network reasoning chains, and trial design specifics are available to verified clinicians, indication researchers, and sponsors under MNDA. Contact management to begin the access request.

Contact management →